Autolus Limited Company
Autolus is a leader in T-cell programming and manufacturing technology.
Industry:
Genomic and Epigenominc Instabillity
Technology:
Cell Therapies
Funding Status:
IPO
Investment Stage:
N/A
Headquarters:
United Kingdom
Employee Number:
11-50
Number Of Exists:
N/A
Investor Type:
N/A
Founded Date:
2014